Heba Hussein Rohym, Mohamed S Hemeda, Almoatazbellah Mahmoud Elsayed, Mayada Saad Farrag, Heba A Elsayed, Amgad A Ezzat, Mohamed A Ibrahim, Mohammed Makloph
{"title":"Interleukin-10 levels in azithromycin-induced cardiac damage and the protective role of combined selenium and vitamin E treatment.","authors":"Heba Hussein Rohym, Mohamed S Hemeda, Almoatazbellah Mahmoud Elsayed, Mayada Saad Farrag, Heba A Elsayed, Amgad A Ezzat, Mohamed A Ibrahim, Mohammed Makloph","doi":"10.1016/j.toxrep.2024.101860","DOIUrl":null,"url":null,"abstract":"<p><p>Azithromycin is a broad-spectrum antibiotic commonly used to treat bacterial infections but is associated with adverse cardiac effects, including oxidative damage and myocardial inflammation. This study aims to explore the histopathological and biochemical changes, including serum interleukin-10 levels, induced by azithromycin in the hearts of male albino rats and to evaluate the protective role of combined selenium and vitamin E treatment. Forty rats were divided into four groups: a control group, an azithromycin treatment group, selenium and vitamin E treatment group, and a combined treatment group receiving both azithromycin, selenium, and vitamin E. Results showed that the azithromycin-treated group exhibited significant increases in interleukin-10 levels, myocardial fibrosis, and cell structure degeneration, while combined selenium and vitamin E treatment markedly reduced these adverse effects, indicating a protective effect. This study concludes that selenium and vitamin E provide a protective effect against azithromycin-induced cardiac toxicity, suggesting that concurrent antioxidant therapy may help safeguard the heart during azithromycin treatment.</p>","PeriodicalId":23129,"journal":{"name":"Toxicology Reports","volume":"14 ","pages":"101860"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11697843/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.toxrep.2024.101860","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"Environmental Science","Score":null,"Total":0}
引用次数: 0
摘要
阿奇霉素是一种广谱抗生素,常用于治疗细菌感染,但对心脏有不良影响,包括氧化损伤和心肌炎。本研究旨在探讨阿奇霉素在雄性白化大鼠心脏中诱导的组织病理学和生化变化,包括血清白细胞介素-10水平,并评估硒和维生素E联合治疗的保护作用。结果表明,阿奇霉素治疗组的白细胞介素-10水平、心肌纤维化和细胞结构变性显著增加,而硒和维生素 E的联合治疗则明显减轻了这些不良反应,显示出保护作用。本研究的结论是,硒和维生素 E 对阿奇霉素诱发的心脏毒性具有保护作用,这表明在阿奇霉素治疗期间,同时进行抗氧化治疗可能有助于保护心脏。
Interleukin-10 levels in azithromycin-induced cardiac damage and the protective role of combined selenium and vitamin E treatment.
Azithromycin is a broad-spectrum antibiotic commonly used to treat bacterial infections but is associated with adverse cardiac effects, including oxidative damage and myocardial inflammation. This study aims to explore the histopathological and biochemical changes, including serum interleukin-10 levels, induced by azithromycin in the hearts of male albino rats and to evaluate the protective role of combined selenium and vitamin E treatment. Forty rats were divided into four groups: a control group, an azithromycin treatment group, selenium and vitamin E treatment group, and a combined treatment group receiving both azithromycin, selenium, and vitamin E. Results showed that the azithromycin-treated group exhibited significant increases in interleukin-10 levels, myocardial fibrosis, and cell structure degeneration, while combined selenium and vitamin E treatment markedly reduced these adverse effects, indicating a protective effect. This study concludes that selenium and vitamin E provide a protective effect against azithromycin-induced cardiac toxicity, suggesting that concurrent antioxidant therapy may help safeguard the heart during azithromycin treatment.